Pharmaceutical Executive
Is Congress harming pharmaceutical research by limiting enforcement of improvement patents?
Robert L. Stoll
Advertisement
Articles by Robert L. Stoll
Advertisement
Latest Updated Articles
- Attacks on Pharmaceutical Improvement Patents
August 21st 2019
Advertisement
Advertisement
Trending on PharmExec
1
The Origins of Nuvation Bio’s Deal with Daichii Sankyo for the Rights to Safusidenib in Japan
2
DTP is Scaling Fast, the Safety Infrastructure is Not
3
Nuvation Bio’s Approach to Building a Compelling Narrative
4
Insilico Medicine and CMS Enter $177 Million AI-Powered Drug Discovery Collaboration
5